By combining several mutations, it was also possible to obtain lymphomas with peripheral B-cell phenotype in which Myc was joined with an Igh switch region sequence and the Eμ enhancer was deleted, leaving Myc under the control of the Igh3’RR alone [19]. The gene discussed is MYC; the disease is lymphoma.